Healthcare Realty Trust (NYSE:HR – Get Free Report) had its target price raised by stock analysts at Wells Fargo & Company from $19.00 to $21.00 in a report issued on Monday,Benzinga reports. The brokerage presently has an “equal weight” rating on the real estate investment trust’s stock. Wells Fargo & Company‘s price objective would indicate a potential upside of 6.03% from the company’s previous close.
Other analysts have also issued reports about the company. Citigroup raised their price objective on Healthcare Realty Trust from $19.00 to $21.00 and gave the company a “neutral” rating in a research note on Thursday, May 7th. UBS Group raised their price objective on Healthcare Realty Trust from $18.00 to $20.00 and gave the company a “buy” rating in a research note on Wednesday, May 13th. Scotiabank raised their price objective on Healthcare Realty Trust from $20.00 to $22.00 and gave the company an “outperform” rating in a research note on Friday, May 8th. Royal Bank Of Canada raised their price objective on Healthcare Realty Trust from $19.00 to $21.00 and gave the company a “sector perform” rating in a research note on Thursday, May 14th. Finally, Cantor Fitzgerald raised their price objective on Healthcare Realty Trust from $21.00 to $22.00 and gave the company an “overweight” rating in a research note on Monday, May 4th. Four equities research analysts have rated the stock with a Buy rating, four have assigned a Hold rating and two have assigned a Sell rating to the company. Based on data from MarketBeat, the stock has an average rating of “Hold” and an average price target of $20.50.
Read Our Latest Stock Analysis on HR
Healthcare Realty Trust Stock Down 0.6%
Healthcare Realty Trust (NYSE:HR – Get Free Report) last released its quarterly earnings data on Thursday, April 30th. The real estate investment trust reported $0.41 earnings per share for the quarter, beating the consensus estimate of $0.39 by $0.02. The business had revenue of $275.28 million for the quarter, compared to analyst estimates of $283.01 million. Healthcare Realty Trust had a negative return on equity of 4.29% and a negative net margin of 17.34%.Healthcare Realty Trust’s revenue was down 7.7% compared to the same quarter last year. During the same period last year, the firm posted $0.39 earnings per share. Healthcare Realty Trust has set its FY 2026 guidance at 1.590-1.65 EPS. Analysts anticipate that Healthcare Realty Trust will post 1.61 EPS for the current year.
Insider Activity at Healthcare Realty Trust
In other news, Director Thomas N. Bohjalian purchased 10,000 shares of the business’s stock in a transaction dated Friday, March 6th. The shares were purchased at an average cost of $18.09 per share, with a total value of $180,900.00. Following the completion of the purchase, the director owned 85,520 shares of the company’s stock, valued at $1,547,056.80. This trade represents a 13.24% increase in their position. The purchase was disclosed in a document filed with the SEC, which is available at this link. Insiders own 0.56% of the company’s stock.
Institutional Trading of Healthcare Realty Trust
Hedge funds have recently made changes to their positions in the company. Allianz Asset Management GmbH boosted its stake in shares of Healthcare Realty Trust by 36.3% during the third quarter. Allianz Asset Management GmbH now owns 527,024 shares of the real estate investment trust’s stock valued at $9,502,000 after purchasing an additional 140,396 shares in the last quarter. Thrivent Financial for Lutherans boosted its stake in shares of Healthcare Realty Trust by 8.8% during the third quarter. Thrivent Financial for Lutherans now owns 5,018,021 shares of the real estate investment trust’s stock valued at $90,475,000 after purchasing an additional 404,855 shares in the last quarter. Aberdeen Group plc raised its position in shares of Healthcare Realty Trust by 26.2% during the fourth quarter. Aberdeen Group plc now owns 391,201 shares of the real estate investment trust’s stock worth $6,631,000 after acquiring an additional 81,273 shares during the last quarter. Bayhunt Capital LLC bought a new position in shares of Healthcare Realty Trust during the fourth quarter worth about $6,216,000. Finally, Cinctive Capital Management LP raised its position in shares of Healthcare Realty Trust by 258.9% during the third quarter. Cinctive Capital Management LP now owns 189,551 shares of the real estate investment trust’s stock worth $3,418,000 after acquiring an additional 136,734 shares during the last quarter.
Healthcare Realty Trust Company Profile
Healthcare Realty Trust (NYSE: HR) is a real estate investment trust specializing in the ownership, acquisition and management of outpatient medical facilities. Headquartered in Nashville, Tennessee, the company’s portfolio is focused primarily on medical office buildings and outpatient healthcare properties that serve hospitals, health systems and other healthcare providers. Its business model centers on securing long-term, triple-net leases to generate stable income streams from a diversified tenant base.
The company’s properties are located across key metropolitan markets in the United States, including major healthcare hubs in the Southeast, Southwest and in select coastal regions.
Further Reading
- Five stocks we like better than Healthcare Realty Trust
- 3 Up-and-Coming Stocks That Could Be the Next NVIDIA
- What Exactly Is Agentic AI, and Why Are Some Stocks Blowing Up Because of It?
- 2 Pick-and-Shovel Plays for Major Digital Infrastructure Buildout
- Best Buy’s AI Laptop Boost Sparks Hope for a BBY Turnaround
Receive News & Ratings for Healthcare Realty Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Healthcare Realty Trust and related companies with MarketBeat.com's FREE daily email newsletter.
